Skip to main content
Linda Boxer, MD, Oncology, Stanford, CA

LindaMBoxerMD

Oncology Stanford, CA

Professor, Medicine - Hematology, Stanford University Medical Center

Are you Dr. Boxer?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 59 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    269 Campus Dr
    Hematology Ccsr 1155
    Stanford, CA 94305
    Phone+1 650-735-4036

Summary

  • Dr. Linda Boxer, MD is an oncologist in Stanford, California. She is currently licensed to practice medicine in California. She is affiliated with Stanford Health Care, Lucile Packard Children's Hospital Stanford, and VA Palo Alto Heath Care.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1984 - 1985
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1981 - 1984
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1981

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1982 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1996

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Laurence “Larry” Kedes, Molecular Geneticist, Dies at 83
    Laurence “Larry” Kedes, Molecular Geneticist, Dies at 83April 26th, 2021
  • Children’s Hospital Los Angeles Chief Scientific Officer Named to California Stem Cell Research Body Governing Board
    Children’s Hospital Los Angeles Chief Scientific Officer Named to California Stem Cell Research Body Governing BoardApril 7th, 2021

Grant Support

  • Activation Of BCL-2 In Hematologic MalignanciesNational Cancer Institute2008–2011
  • Training Program In Investigative HematologyNational Heart, Lung, And Blood Institute2004–2010
  • Activation Of BCL-2 In Hematologic MalgnanciesNational Cancer Institute2007
  • Activation Of BCL-2 In Hematologic MalignanciesNational Cancer Institute1993–2006
  • Control Of C-MYC Transcription In High Grade LymphomaNational Cancer Institute2002–2005
  • Molecular Studies Of Human AllNational Cancer Institute2001–2004
  • Control Of MYC Transcription In High Grade LymphomaNational Cancer Institute2001
  • Activation Of BCL 2 In Hematologic MalignanciesNational Cancer Institute1998–2001
  • Regulation Of Expression Of C-MYB In LeukemiasNational Cancer Institute1996–2000
  • Control Of C MYC Transcription In High Grade LymphomasNational Cancer Institute1996–2000
  • Control Of C-MYC Transcription In Aggressive LymphomasNational Cancer Institute1996–1999